7 unchanged sentences
Management’s Report on Internal Control over Financial Reporting
−Removed: This Annual Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the company's independent registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies.
+Added: Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).
+Added: We maintain internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
+Added: Under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria set forth in “Internal Control—Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).
+Added: Based on this assessment, our management concluded that our internal control over financial reporting was effective at the reasonable assurance level as of December 31, 2025.
+Added: This Annual Report does not include an attestation report of our registered public accounting firm due to an exemption established by the JOBS Act for “emerging growth companies.”
Changes in Internal Control over Financial Reporting
7 unchanged sentences
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls.
−Removed: The design of any system of controls is also based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate.
+Added: The design of any system of controls is also based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may
Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
17 unchanged sentences
Exhibits and Financial Statement Schedules.
−Removed: The following documents are filed as part of this Annual Report:
+Added: (a) The following documents are filed as part of this Annual Report:
(1) Financial Statements .
2 unchanged sentences
Financial statement schedules have been omitted in this Annual Report because they are not applicable, not required under the instructions, or the information requested is set forth in the financial statements or notes thereto.
+Added: (3) Exhibits .
The following is a list of exhibits filed or furnished as part of this Annual Report on Form 10-K.
−Removed: Incorporated by Reference
+Added: Incorporated by Reference Filed
+Added: Number Description Form File No.
+Added: Exhibit Filing Date Herewith
3.1 Amended and Restated Certificate of Incorporation of the Registrant.
+Added: 8-K 001-42001 3.1 04/09/2024
3.2 Amended and Restated Bylaws of the Registrant.
+Added: 8-K 001-42001 3.2 04/09/2024
4.1 Form of Registrant’s Class A common stock certificate.
+Added: S-1/A 333-278003 4.1 04/01/2024
4.2 Description of the Registrant’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934.
+Added: 10-K 001-42001 4.2 03/06/2025
4.3 Amended and Restated Investors’ Rights Agreement, dated February 9, 2021, by and among the Registrant and the other parties thereto.
+Added: S-1 333-278003 4.2 03/15/2024
Warrant to Purchase Stock, issued to Silicon Valley Bank, dated as of September 1, 2020.
+Added: S-1 333-278003 4.3 03/15/2024
4.5 Letter Agreement, dated as of July 9, 2021, by and among the Registrant, Baker Bros.
+Added: S-1 333-278003 4.4 03/15/2024
4.6 Amended and Restated Registration Rights Agreement dated as of July 9, 2021, by and between the Registrant, 667, L.P.
and Baker Brothers Life Sciences, L.P.
+Added: S-1 333-278003 4.5 03/15/2024
10.1+ Form of Indemnity Agreement between the Registrant and each of its directors and executive officers.
+Added: S-1/A 333-278003 10.1 04/01/2024
10.2+ Contineum Therapeutics, Inc.
2012 Equity Incentive Plan, as amended, and forms of agreements thereunder.
+Added: S-1 333-278003 10.2 03/15/2024
10.3+ Contineum Therapeutics, Inc.
2024 Equity Incentive Plan and forms of agreements thereunder.
+Added: S-1/A 333-278003 10.3 04/01/2024
10.4+ Contineum Therapeutics, Inc.
2024 Employee Stock Purchase Plan.
+Added: S-1/A 333-278003 10.4 04/01/2024
10.5+ Offer Letter, dated as of August 14, 2018, by and between the Registrant and Carmine Stengone.
+Added: S-1/A 333-278003 10.5 04/01/2024
10.6+ Offer Letter, dated as of March 9, 2018, as amended by Amendment to Original Offer Letter, dated as of December 16, 2021, each by and between the Registrant and Daniel Lorrain, Ph.D.
+Added: S-1/A 333-278003 10.6 04/01/2024
10.7+ Offer Letter, dated as of August 20, 2020, by and between the Registrant and Peter Slover.
+Added: S-1/A 333-278003 10.7 04/01/2024
10.8+ Offer Letter, dated May 28, 2024, by and between the Registrant and John Healy.
−Removed: Offer Letter, dated as of December 12, 2019 by and between the Registrant and Stephen Huhn, M.D.
+Added: 10-Q 001-42001 10.2 08/14/2024
Contineum Therapeutics, Inc.
Executive Severance Plan .
+Added: 8-K 001-42001 10.1 05/31/2024
Form of Registrant’s Mutual Arbitration Agreement.
−Removed: Contineum Therapeutics, Inc.
−Removed: Non-Employee Director Compensation Program.
−Removed: Lease Agreement, dated January 3, 2018, by and between ARE-SD Region No.
−Removed: 44, LLC and the Registrant.
−Removed: First Amendment to Lease dated February 16, 2018, by and between ARE-SD Region No.
−Removed: 44, LLC and the Registrant.
−Removed: Second Amendment to Lease, dated April 2, 2018, by and between ARE-SD Region No.
−Removed: 44, LLC and the Registrant.
−Removed: Third Amendment to Lease, dated June 15, 2021, by and between ARE-SD Region No.
−Removed: 44, LLC and the Registrant.
−Removed: Lease Termination, dated October 25, 2023, by and between ARE-SD Region No.
−Removed: 44, LLC and the Registrant.
+Added: 8-K 001-42001 10.2 05/31/2024
Lease Agreement, dated October 25, 2023, by and between ARE-3535/3566 General Atomics Court, LLC and the Registrant.
−Removed: Loan and Security Agreement, dated as of September 1, 2020, by and between the Registrant and Silicon Valley Bank.
−Removed: First Amendment to Loan and Security Agreement, dated as of March 15, 2021, by and between the Registrant and Silicon Valley Bank.
+Added: S-1 333-278003 10.13 03/15/2024
License Agreement, dated February 3, 2023, by and between the Registrant and Janssen Pharmaceutica NV.
+Added: S-1 333-278003 10.16 03/15/2024
+Added: Offer Letter, dated as of April 3, 2025, by and between the Registrant and Tim Watkins.
+Added: 10-Q 001-42001 10.1 08/05/2025
+Added: Amendment to Offer Letter, dated as of April 18, 2025, by and between the Registrant and Tim Watkins.
+Added: 10-Q 001-42001 10.2 08/05/2025
+Added: 10.15 Sales Agreement, dated May 14, 2025, by and between Contineum Therapeutics, Inc.
+Added: and Leerink Partners.
+Added: 1.2 05/14/2025
+Added: 10.16 2026 Employment Inducement Equity Incentive Plan and forms of agreements thereunder.
+Added: Amended Contineum Therapeutics, Inc.
+Added: Non-Employee Director Compensation Program.
Contineum Therapeutics, Inc.
Insider Trading Policy.
+Added: 10-K 001-42001 19.1 03/06/2025
21.1 List of Subsidiaries.
+Added: 10-K 001-42001 21.1 03/06/2025
23.1 Consent of Independent Registered Public Accounting Firm.
8 unchanged sentences
Policy for the Recovery of Erroneously Awarded Compensation
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
−Removed: Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
+Added: 10-K 001-42001 97.1 03/06/2025
+Added: 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
21 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
+Added: Name Title Date
/s/ Carmine Stengone
−Removed: Carmine Stengone
−Removed: President, Chief Executive Officer and Director
+Added: Carmine Stengone President, Chief Executive Officer and Director
( Principal Executive Officer )
1 unchanged sentence
/s/ Peter Slover
−Removed: Chief Financial Officer
+Added: Peter Slover Chief Financial Officer
( Principal Financial Officer and Accounting Officer )
1 unchanged sentence
/s/ Evert Schimmelpennink
−Removed: Evert Schimmelpennink
−Removed: Chairperson of the Board of Directors
−Removed: March 6, 2025
+Added: Evert Schimmelpennink Chairperson of the Board of Directors March 5, 2026
/s/ Lori Lyons-Williams
−Removed: Lori Lyons-Williams
−Removed: March 6, 2025
+Added: Lori Lyons-Williams Director March 5, 2026
+Added: /s/ Diego Miralles
+Added: Diego Miralles Director March 5, 2026
/s/ Todd Brady
−Removed: March 6, 2025
+Added: Todd Brady Director March 5, 2026
/s/ Olivia Ware
−Removed: March 6, 2025
+Added: Olivia Ware Director March 5, 2026
/s/ Sarah Boyce
−Removed: March 6, 2025
+Added: Sarah Boyce Director March 5, 2026
/s/ Troy Ignelzi
−Removed: March 6, 2025
+Added: Troy Ignelzi Director March 5, 2026
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.